31 October 2019
Visiongain’s new report the Spirometer Market Report 2020-2030: Forecasts by Product (Hand Held, Table Top, and Desktop), by Technology (Flow Measurement, Peak Flow Measurement, Volume Measurement), by Application (COPD, Asthma, Pulmonary Fibrosis, Cystic Fibrosis, and Others) by End Use (Home Use and Hospitals & Clinics) plus analysis of leading companies indicates that the global spirometer market will cross 1.5 billion revenue by 2030.
Global Spirometer Market is expected to grow on account of its rising demand from multispecialty hospitals pertaining to rising prevalence of lung disorders amongst teenagers and children. With increasing pollution across the globe, problems such as chest congestion, smoke allergies result in hospital admission where doctors often use spirometer for evaluating patient’s lung capacity.
The exponential increase in the incidence of COPD coupled with rising air pollution levels in developing economies like China and India are likely to drive the demand for spirometers within these countries. Technological improvements with respect to monitoring coupled with extensive pipeline research on anti-asthmatic drugs are expected to propel the market growth for spirometers in coming years.
Manufacturers have started design improvement from traditional spirometers to advanced ones. Of which peak flow meters come with innovative features enabling ease for the patient for using the device. Key players are concentrating on offering easy to use spirometers in order to increase their presence and gain competitive advantage over other market players.
Presence of large pool of patients suffering from COPD and asthma coupled with large ratio of new born with child asthma reflect the growth in demand for spirometers in developed as well as developing economies. As per Department of Health in the U.S., in 2011, over 800,000 people were diagnosed with COPD and the rate of diagnosis has went up to 27% in last 10 years.
On the basis of product, introduction of compact spirometers by many leading manufacturers have been a remarkable milestone. These compact spirometers being easy to carry have gained utmost popularity especially for home use. However, desktop spirometers are likely to grow at a fastest growth rate compared to counterparts pertaining to integration of computer technology in it. This computer based spirometers display integrated data for clinical decisions. Such characteristics are likely to fuel the segment growth by 2030.
In terms of technology, peak flow spirometers are likely to show most lucrative growth by 2030 on account of modern design and compatibility with oximeter. Peak flow spirometers enables breathing pattern and ventilation monitoring making it first choice of medical practitioners.
Within the application segment, COPD is likely to hold maximum market share in on account of high prevalence of COPD in children and teenagers in top 5 populous countries. Additionally, high pollution levels in these countries often make people prone to lung disorders making lung diagnosis essential where spirometers act as a must have equipment.
In terms of region, Asia Pacific is likely to emerge as a most lucrative market for spirometer on account of rising geriatric population in Japan coupled with rapid industrialization in India causing air pollution.
- Welch Allyn
- Koninklijke Philips N.V.
- Geratherm Respiratory GmbH
- FUKUDA SANGYO CO., LTD.
- VYAIRE MEDICAL, INC.
- Smiths Medical
- Nihon Kohden Corporation
- NSPIRE HEALTH INC
- Labtech Ltd.
- SDI Diagnostics
- Ganshorn Medizin Electronic
- Cosmed srl
- Medset Medizintechnik GmbH
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The mesenchymal stem cells market was valued at US$2.44 billion in 2021 and is projected to grow at a CAGR of 13.82% during the forecast period 2022-2032.
21 September 2022
The global advanced wound care management market is estimated to be valued at US$12,581.3 million in 2022. The market is projected to reach a market value of US$23,307.5 million by 2032 and is projected to grow at a CAGR of 6.36% during the forecast period 2022-2032.
16 September 2022
The gene therapy R&D market was valued at US$1,653.0 million in 2021 and is projected to grow at a CAGR of 30.1% during the forecast period 2022-2032.
15 September 2022
The medical device contract manufacturing market was valued at US$69.22 billion in 2021 and is projected to grow at a CAGR of 12.9% during the forecast period 2022-2032.